Abstract
Prostate tissue was obtained from 22 radical prostatectomies (performed for clinical management of prostate carcinoma) immediately after surgery. A small piece of tissue was fixed immediately in formalin and used for routine histology while a second piece was frozen in OCT and used for immuno-histochemistry. Another small piece was used for isolation of epithelial and stromal cells. The remainder of the tissue was cut into 2 × 2 mm pieces and incubated in organ culture for 8 days. In organ culture, non-malignant, basal epithelial cells underwent a proliferative response. This was accompanied by de-differentiation of glandular structures and by migration of epithelial cells across the surface of the tissue. Erosion of the basement membrane could also be seen in places, but was not widespread. Invasion of epithelial cells into the adjacent stroma was not evident. Production of matrix metalloproteinases (MMPs) with gelatinolytic activity or collagenolytic activity was assessed in organ culture and compared to expression patterns in fresh tissue. MMP-1 (interstitial collagenase) and MMP-9 (92-kDa gelatinase B) were undetectable or low in fresh tissue specimens. Both enzymes were detected in organ culture and both increased over time. Even after 6 days, however, there was only a low level of gelatin-hydrolytic activity and no measurable collagen-hydrolytic activity. In past studies we used organ cultures of normal skin and malignant skin tumours (basal cell carcinomas) to help elucidate the role of collagenolytic and gelatinolytic MMPs in epithelial cell invasion (Varani et al, 2000). Compared to MMP levels observed in skin, levels of these enzymes in prostate are low. The low level of collagenolytic and gelatinolytic MMPs in fresh prostate tissue and in organ-cultured prostate tissue may help explain why there is little tissue destruction in many primary prostate tumours and why the majority of such tumours remain confined to the prostate for extended periods. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alexander CM and Werb Z (1992) Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol 118: 727–739
Azzam HS, Arand G, Lippman ME and Thompson EW (1993) Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 1758–1764
Bauer EA, Gordon JM, Reddick ME and Eisen AZ (1977) Quantitation and immunochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol 69: 363–367
Cha H-J, Bae S-K, Lee HY, Sato H, Seiki M, Park C and Kim K-W (1996) Anti-invasive activity of urosolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res 56: 2281–2284
Chi Y, Zeigler ME, Walker J, Perone P, Datta SC and Varani J (1998) Elaboration of matrix metalloproteinase inhibitors by human skin in organ culture and by skin cells in monolayer culture: Relationship to invasion. Invasion & Metastasis 18: 27–34
Crawford HC and Matrisian LM (1996) Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49: 20–37
DeClerck YA, Yean T-D, Chan D, Shimada H and Langley KE (1991) Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 51: 2151–2157
DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE and Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708
Festuccia C, Bologna M, Vicentini C, tacconelli A, Miano R, Violini S and Mackay AR (1996) Increased matrix metalloproteinase-9 secretion in short-term cultures of prostatic tumor cells. Int J Cancer 69: 386–393
Fisher GJ, Datta SC, Talwar HS, Wang Z-Q, Varani J, Kang S and Voorhees JJ (1996) Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature (London) 379: 335–339
Fligiel SEG and Varani J (1993) In situ epithelial cell invasion in organ culture. Invasion & Metastasis 13: 225–233
Geller J, Sionit LR, Connors K and Hoffman RM (1992) Measurement of androgen sensitivity in the human prostate in vitro three dimensional histoculture. Prostate 21: 269–278
Gibbs DF, Warner RO, Weiss SJ, Varani J and Johnson KJ (1999) Role of matrix metalloproteinases in lung injury in models of macrophage-dependent acute lung injury: Evidence for the macrophages as the source of the proteinases. Amer J Respiratory Cell Molecular Biol 20: 1145–1154
Goslen JB and Bauer EA (1986) Basal cell carcinoma and collagenase. J Dermatol Surg Oncol 12: 812–817
Gray ST, Wilkins RJ and Yun K (1992) Interstitial collagenase gene expression in oral squamous cell carcinoma. Amer J Pathol 141: 301–306
Hamdy FC, Fadlon EJ, Cottain D, Lawry J, Thurrell W, Silcocks PB, Anderson JB, Williams JL and Rees RC (1994) Matrix metalloproteinase 9 expression in primary prostatic adenocarcinoma and benign prostatic hypeplasia. Br J Cancer 69: 177–182
Imren S, Kohn DB, Shimad H, Blavier L and DeClerck YA (1966) Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res 56: 2891–2895
Johansson N, Airola K, Grenman R, Kariniemi A-L, saarialho- Kere U and Kahari V-M (1997) Expression of collagenase-3 (MMP-13) in squamous cell carcinomas of the head and neck. Amer J Pathol 151: 499–508
Jung K, Nowak L, Lein M, Priem F, Schnorr D and Loening SA (1997) Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer. Int J Cancer 74: 220–223
Key G, Becker MH, Baron B, Duchrow M, Schluter C, Flad HD and Gerdes J (1993) New Ki-67-equivalent murine monoclonal antibodies (MIB-1-3) generated against bacterially expressed parts of Ki-67 cDNA containing three 62 base pair repetitive elements. Lab Invest 68: 629–636
Khokha R and Denhardt DT (1989) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: a review of their role in tumorigenicity and tissue invasion. Invasion & Metastasis 9: 391–405
Khokha R, Waterhouse P, Yagel S, Lala P, Overall C, Norton G and Denhardt D (1989) Antisense RNA-induced reduction in TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 244: 947–950
Lokeshwar BL, Selzer MG, Blook NL and Gunja-Smith Z (1993) Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant culture: Reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res 53: 4493–4498
MacDougall JR, Bani MR, Lin Y, Rak J and Kerbel RS (1995) The 92 kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic hybridization with early stage melanoma cells. Cancer Res 55: 4174–4181
Majmudar G, Nelson B, Jensen TC, Voorhees JJ and Johnson TM (1994) Increased expression of stromelysin-3 in basal cell carcinomas. Mol Carcinogen 9: 17–23
Makin CA, Babrow LG and Bodner WF (1984) Monoclonal antibody to cytokaratin for use in routine histopathology. J Clin Pathol 37: 395–404
McDonnell S, Navre M, Coffey RJ jr and Matrisian LM (1991) Expression and localization of the matrix metalloproteinase pump-1 in human gastric and colon carcinomas. Mol Carcinogen 4: 527–533
Montironi R, Fabris G, Lucarini G and Biagini G (1995) Location of 72-kd metalloproteinase (type IV collagenase) in untreated prostatic adenocarcinoma. Path Res Pract 191: 1140–1146
Montironi R, Lucarini G, Castaldini C, Galluzzi CM, Biagini G and Fabris G (1996) Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Anticancer Res 16: 2057–2062
Muller D, Breathnach R, Englelmann A, Millon R, Bronner G, Flesch H, Dumont P, Eber M and Abecassis J (1991) Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 48: 550–556
Muller D, Wolf C, Abecassis J, Millon R, Engelmann A, Bronner G, Rouyer N, Rio M, Eber M, Methlin G, Chambon P and Basset P (1993) Increased stromelysin-3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 53: 165–169
Mulligan MS, Desrochers PE, Chinnaiyan AM, Gibbs DF, Varani J, Johnson KJ and Weiss SJ (1993) In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinase-2. Proc Nat Acad Sci 90: 11523–11527
Murphy G and Docherty AJP (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7: 120–125
Murray GI, Duncan ME, O’Neil P, Melvin WT and Fothergill JE (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature Med 2: 461–462
Muschel R, Williams J, Lowy D and Liotta L (1985) Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. Am J Pathol 121: 1–8
Nevalainen MT, Harkonen PL, Valve EM, Ping W, Nurmi M and Martikainen PM (1993) Hormone regulation of human prostate in organ culture. Cancer Res 53: 5199–5207
Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK and Bowden GT (1991) Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 117: 144–150
Pretlow TG, Yang B and Pretlow TP (1995) Organ culture of benign, aging and hyperplastic human prostate. Microscopic Res Tech 30: 271–281
Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K and Tryggvason K (1992) Localization of messenger RNA for Mr72,000 and 92,000 type IV collagenase in human skin cancers by in situ hybridization. Cancer Res 532: 1336–1341
Schrodt GR and Foreman CD (1971) In vitro maintenance of human hyperplastic prostate tissue. Invest Urol 9: 85–94
Stearns ME and Wang M (1993) Type IV collagenase (Mr 72,000) expression in human prostate: Benign and malignant tissue. Cancer Res 53: 878–883
Still K, Robson CN, Autzen P, Robinson MC and Hamdy FC (2000) Localization and quantitation of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue. The Prostate 42: 18–25
Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ and Cher ML (1999) Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res 5: 4105–4110
Varani J, Perone P, Inman DR, Burmeister W, Scholenberger SB, Fligiel SEG, Sitrin RG and Johnson KJ (1995) Human skin in organ culture: Elaboration of proteolytic enzymes in the presence and absence of exogenous growth factors. Amer J Pathol 146: 210–217
Varani J, Dame MK, Wojno K, Schuger L and Johnson KJ (1999) Characteristics of nonmalignant and malignant human prostate in organ culture. Lab Invest 79: 723–731
Varani J, Hattori Y, Chi Y, Schmidt T, Zeigler ME, Fader D and Johnson TM (2000) Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: Comparison with normal skin. Brit J Cancer 82: 657–665
Wilson MJ, Norris H, Kapoor D, Woodson M, Limas C and Sinha AA (1993) Gelatinolytic and caseinolytic proteinase activities in human prostate secretions. J Urology 149: 653–658
Zeigler ME, Dutcheshen NT, Gibbs DFG and Varani J (1996) Growth factor-induced epidermal invasion of the dermis in human skin organ culture: Expression and role of matrix metalloproteinases. Invasion & Metastasis 16: 11–18
Zeigler ME, Chi Y, Schmidt T and Varani J (1999) Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 180: 271–284
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Varani, J., Hattori, Y., Dame, M. et al. Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue. Br J Cancer 84, 1076–1083 (2001). https://doi.org/10.1054/bjoc.2000.1712
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2000.1712
Keywords
This article is cited by
-
The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer
Cell Death & Disease (2014)
-
Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer
World Journal of Urology (2011)
-
Study of matrix metalloproteinases and their inhibitors in prostate cancer
British Journal of Cancer (2010)
-
Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue
Prostate Cancer and Prostatic Diseases (2003)
-
Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies
British Journal of Cancer (2002)
